Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    July 2017
  1. NELSEN LM, Vernon M, Ortega H, Cockle SM, et al
    Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;128:42-49.
    PubMed     Text format     Abstract available


  2. SUAREZ-CUARTIN G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, et al
    Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.
    Respir Med. 2017;128:1-6.
    PubMed     Text format     Abstract available


    June 2017
  3. BLAIS CM, Davis BE, Cockcroft DW
    "Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics" [Respiratory Medicine 118 (September 2016) 96-101].
    Respir Med. 2017 Jun 30. pii: S0954-6111(17)30181.
    PubMed     Text format    


  4. SALEH AD, Chalmers JD, De Soyza A, Fardon TC, et al
    The heterogeneity of systemic inflammation in bronchiectasis.
    Respir Med. 2017;127:33-39.
    PubMed     Text format     Abstract available


  5. PLOURDE A, Lavoie KL, Raddatz C, Bacon SL, et al
    Effects of acute psychological stress induced in laboratory on physiological responses in asthma populations: A systematic review.
    Respir Med. 2017;127:21-32.
    PubMed     Text format     Abstract available


    May 2017
  6. SCHOR D, Rizzo JA, Medeiros D, Dela Bianca AC, et al
    Home-made spacer as an auxiliary device in administration of beclomethasone via pressurized metered dose inhaler for asthma control. A randomized controlled pragmatic trial.
    Respir Med. 2017;126:52-58.
    PubMed     Text format     Abstract available


  7. BREUER O, Daum H, Cohen-Cymberknoh M, Unger S, et al
    Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.
    Respir Med. 2017;126:39-45.
    PubMed     Text format     Abstract available


  8. NELSEN LM, Kimel M, Murray LT, Ortega H, et al
    Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;126:32-38.
    PubMed     Text format     Abstract available


  9. FERRER GALVAN M, Javier Alvarez Gutierrez F, Romero Falcon A, Romero Romero B, et al
    Is the bronchodilator test an useful tool to measure asthma control?
    Respir Med. 2017;126:26-31.
    PubMed     Text format     Abstract available


  10. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Corrigendum to "Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial" [Respir. Med. 120 (November 2016)
    Respir Med. 2017;126:25.
    PubMed     Text format    


    April 2017
  11. NADEAU M, Boulay ME, Milot J, Lepage J, et al
    Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.
    Respir Med. 2017;125:82-88.
    PubMed     Text format     Abstract available


  12. RASTOGI D, Jung M, Strizich G, Shaw PA, et al
    Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults.
    Respir Med. 2017;125:72-81.
    PubMed     Text format     Abstract available


  13. AKIKI Z, Rava M, Diaz Gil O, Pin I, et al
    Serum cytokine profiles as predictors of asthma control in adults from the EGEA study.
    Respir Med. 2017;125:57-64.
    PubMed     Text format     Abstract available


  14. JEONG A, Imboden M, Hansen S, Zemp E, et al
    Heterogeneity of obesity-asthma association disentangled by latent class analysis, the SAPALDIA cohort.
    Respir Med. 2017;125:25-32.
    PubMed     Text format     Abstract available


    March 2017
  15. DATTA S, Nam HS, Hayashi M, Maldonado L, et al
    Expression of GULP1 in bronchial epithelium is associated with the progression of emphysema in chronic obstructive pulmonary disease.
    Respir Med. 2017;124:72-78.
    PubMed     Text format     Abstract available


  16. TIWARI A, Rahman K, Abejie B, Jain VV, et al
    Longer duration of asthma is significantly associated with increased RV/TLC ratio.
    Respir Med. 2017;124:44-48.
    PubMed     Text format     Abstract available


  17. MANSUR AH, Srivastava S, Mitchell V, Sullivan J, et al
    Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety.
    Respir Med. 2017;124:36-43.
    PubMed     Text format     Abstract available


  18. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    The level of diagnostic assessment in severe asthma: A nationwide real-life study.
    Respir Med. 2017;124:21-29.
    PubMed     Text format     Abstract available


    February 2017
  19. SILVERMAN RA, Hasegawa K, Egan DJ, Stiffler KA, et al
    Multicenter study of cigarette smoking among adults with asthma exacerbations in the emergency department, 2011-2012.
    Respir Med. 2017 Feb 7. pii: S0954-6111(17)30025.
    PubMed     Text format     Abstract available


  20. VEIDAL S, Jeppegaard M, Sverrild A, Backer V, et al
    The impact of dysfunctional breathing on the assessment of asthma control.
    Respir Med. 2017;123:42-47.
    PubMed     Text format     Abstract available


  21. BJERREGAARD A, Laing IA, Poulsen N, Backer V, et al
    Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
    Respir Med. 2017;123:34-41.
    PubMed     Text format     Abstract available


  22. COCKLE SM, Stynes G, Gunsoy NB, Parks D, et al
    Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.
    Respir Med. 2017;123:140-148.
    PubMed     Text format     Abstract available


  23. VARSANO S, Segev D, Shitrit D
    Severe and non-severe asthma in the community: A large electronic database analysis.
    Respir Med. 2017;123:131-139.
    PubMed     Text format     Abstract available


  24. TAKAKU Y, Kurashima K, Ohta C, Ishiguro T, et al
    How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Respir Med. 2017;123:110-115.
    PubMed     Text format     Abstract available


  25. ARMSTRONG HF, Lovasi GS, Soliman EZ, Heckbert SR, et al
    Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.
    Respir Med. 2017;123:1-7.
    PubMed     Text format     Abstract available


    January 2017
  26. ADEYEYE OO, Adewumi TA, Adewuya AO
    Effect of psychological and other factors on quality of life amongst asthma outpatients in Lagos, Nigeria.
    Respir Med. 2017;122:67-70.
    PubMed     Text format     Abstract available


  27. HALLIT S, Raherison C, Waked M, Salameh P, et al
    Validation of asthma control questionnaire and risk factors affecting uncontrolled asthma among the Lebanese children's population.
    Respir Med. 2017;122:51-57.
    PubMed     Text format     Abstract available


    December 2016
  28. CHECKLEY W, Deza MP, Klawitter J, Romero KM, et al
    Identifying biomarkers for asthma diagnosis using targeted metabolomics approaches.
    Respir Med. 2016;121:59-66.
    PubMed     Text format     Abstract available


  29. CHEN JH, Qin L, Shi YY, Feng JT, et al
    IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.
    Respir Med. 2016;121:48-58.
    PubMed     Text format     Abstract available


  30. MONTEAGUDO M, Rodriguez-Blanco T, Barrecheguren M, Simonet P, et al
    Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study.
    Respir Med. 2016;121:26-31.
    PubMed     Text format     Abstract available


  31. COMARU T, Pitrez PM, Friedrich FO, Silveira VD, et al
    Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).
    Respir Med. 2016;121:21-25.
    PubMed     Text format     Abstract available


    November 2016
  32. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Respir Med. 2016;120:78-86.
    PubMed     Text format     Abstract available


  33. JANSSON SA, Axelsson M, Hedman L, Leander M, et al
    Subjects with well-controlled asthma have similar health-related quality of life as subjects without asthma.
    Respir Med. 2016;120:64-69.
    PubMed     Text format     Abstract available


  34. DEL GIACCO SR, Cappai A, Gambula L, Cabras S, et al
    The asthma-anxiety connection.
    Respir Med. 2016;120:44-53.
    PubMed     Text format     Abstract available


  35. LAHELMA S, Vahteristo M, Metev H, Taseva M, et al
    Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Respir Med. 2016;120:31-35.
    PubMed     Text format     Abstract available


  36. ALI Z, Nilas L, Ulrik CS
    Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: A case control study.
    Respir Med. 2016;120:124-130.
    PubMed     Text format     Abstract available


  37. APIKOGLU-RABUS S, Yesilyaprak G, Izzettin FV
    Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;120:109-115.
    PubMed     Text format     Abstract available


  38. LARSEN K, Faulkner GE, Boak A, Hamilton HA, et al
    Looking beyond cigarettes: Are Ontario adolescents with asthma less likely to smoke e-cigarettes, marijuana, waterpipes or tobacco cigarettes?
    Respir Med. 2016;120:10-15.
    PubMed     Text format     Abstract available


    October 2016
  39. ANDRIANOPOULOS V, Celli BR, Franssen FM, Pinto-Plata VM, et al
    Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.
    Respir Med. 2016;119:87-95.
    PubMed     Text format     Abstract available


  40. ARFE A, Blasi F, Merlino L, Corrao G, et al
    Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation.
    Respir Med. 2016;119:7-12.
    PubMed     Text format     Abstract available


  41. ENGELKES M, Janssens HM, de Ridder MA, Sturkenboom MC, et al
    Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
    Respir Med. 2016;119:48-54.
    PubMed     Text format     Abstract available


  42. ZIERAU L, Gade EJ, Lindenberg S, Backer V, et al
    Coexistence of asthma and polycystic ovary syndrome: A concise review.
    Respir Med. 2016;119:155-159.
    PubMed     Text format     Abstract available


  43. SPOSATO B, Scalese M, Latorre M, Scichilone N, et al
    Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.
    Respir Med. 2016;119:141-149.
    PubMed     Text format     Abstract available


  44. BELLELLI G, Chalmers JD, Sotgiu G, Dore S, et al
    Characterization of bronchiectasis in the elderly.
    Respir Med. 2016;119:13-19.
    PubMed     Text format     Abstract available


  45. PETHERICK ES, Pearce N, Sunyer J, Wright J, et al
    Ethnic and socio-economic differences in the prevalence of wheeze, severe wheeze, asthma, eczema and medication usage at 4 years of age: Findings from the Born in Bradford birth cohort.
    Respir Med. 2016;119:122-129.
    PubMed     Text format     Abstract available


  46. BRAITHWAITE I, Williams M, Power S, Pilcher J, et al
    Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Respir Med. 2016;119:115-121.
    PubMed     Text format     Abstract available


  47. OCAL S, Portakal O, Ocal A, Demir AU, et al
    Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects.
    Respir Med. 2016;119:109-114.
    PubMed     Text format     Abstract available


  48. EFTEKHARI P, Forder PM, Majeed T, Byles JE, et al
    Impact of asthma on mortality in older women: An Australian cohort study of 10,413 women.
    Respir Med. 2016;119:102-108.
    PubMed     Text format     Abstract available


  49. MORI K, Fujisawa T, Inui N, Hashimoto D, et al
    Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Respir Med. 2016;119:1-6.
    PubMed     Text format     Abstract available


    September 2016
  50. WESTERHOF GA, de Groot JC, Amelink M, de Nijs SB, et al
    Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma.
    Respir Med. 2016;118:122-7.
    PubMed     Text format     Abstract available


  51. GRZELA K, Litwiniuk M, Krejner A, Zagorska W, et al
    Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression?
    Respir Med. 2016;118:119-21.
    PubMed     Text format     Abstract available


  52. DAHL R, Engel M, Dusser D, Halpin D, et al
    Safety and tolerability of once-daily tiotropium Respimat((R)) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Respir Med. 2016;118:102-11.
    PubMed     Text format     Abstract available


  53. BLAIS CM, Davis BE, Cockcroft DW
    Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2016;118:96-101.
    PubMed     Text format     Abstract available


  54. KONDLA A, Glaab T, Pedersini R, Lommatzsch M, et al
    Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
    Respir Med. 2016;118:58-64.
    PubMed     Text format     Abstract available


  55. CHAUDHURI R, McSharry C, Heaney LG, Niven R, et al
    Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma.
    Respir Med. 2016;118:46-52.
    PubMed     Text format     Abstract available


  56. SELGE C, Thomas S, Nowak D, Radon K, et al
    Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines.
    Respir Med. 2016;118:15-21.
    PubMed     Text format     Abstract available


  57. SUAREZ-MEDINA R, Venero-Fernandez SJ, Britton J, Fogarty AW, et al
    Population-based weight loss and gain do not explain trends in asthma mortality in Cuba: A prospective study from 1964 to 2014.
    Respir Med. 2016;118:4-6.
    PubMed     Text format     Abstract available


  58. TAN JH, Hsu AA
    Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Respir Med. 2016;118:1-3.
    PubMed     Text format     Abstract available


    August 2016
  59. MATULONGA B, Rava M, Siroux V, Bernard A, et al
    Women using bleach for home cleaning are at increased risk of non-allergic asthma.
    Respir Med. 2016;117:264-71.
    PubMed     Text format     Abstract available


  60. BECERRA MB, Becerra BJ, Teodorescu M
    Healthcare burden of obstructive sleep apnea and obesity among asthma hospitalizations: Results from the U.S.-based Nationwide Inpatient Sample.
    Respir Med. 2016;117:230-6.
    PubMed     Text format     Abstract available


  61. TUOMISTO LE, Ilmarinen P, Niemela O, Haanpaa J, et al
    A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study.
    Respir Med. 2016;117:223-9.
    PubMed     Text format     Abstract available


  62. CRISAFULLI E, Alfieri V, Silva M, Aiello M, et al
    Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients.
    Respir Med. 2016;117:207-14.
    PubMed     Text format     Abstract available


  63. KERSTJENS HA, Moroni-Zentgraf P, Tashkin DP, Dahl R, et al
    Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Respir Med. 2016;117:198-206.
    PubMed     Text format     Abstract available


  64. WILSON R, Aksamit T, Aliberti S, De Soyza A, et al
    Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.
    Respir Med. 2016;117:179-89.
    PubMed     Text format     Abstract available


  65. RADHAKRISHNA N, Tay TR, Hore-Lacy F, Hoy R, et al
    Profile of difficult to treat asthma patients referred for systematic assessment.
    Respir Med. 2016;117:166-73.
    PubMed     Text format     Abstract available


  66. NAQVI M, Khachi H
    The barriers to accessing primary care resulting in hospital presentation for exacerbation of asthma or chronic obstructive pulmonary disease in a large teaching hospital in London.
    Respir Med. 2016;117:162-5.
    PubMed     Text format     Abstract available


  67. LICCARDI G, Salzillo A, Calzetta L, Cazzola M, et al
    Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics.
    Respir Med. 2016;117:150-3.
    PubMed     Text format     Abstract available


  68. GORSKA K, Korczynski P, Mierzejewski M, Kosciuch J, et al
    Comparison of endobronchial ultrasound and high resolution computed tomography as tools for airway wall imaging in asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;117:131-8.
    PubMed     Text format     Abstract available


  69. VERMEULEN F, Garcia G, Ninane V, Laveneziana P, et al
    Activity limitation and exertional dyspnea in adult asthmatic patients: What do we know?
    Respir Med. 2016;117:122-30.
    PubMed     Text format     Abstract available


  70. HARTMAN JE, Klooster K, Slebos DJ, Ten Hacken NH, et al
    Improvement of physical activity after endobronchial valve treatment in emphysema patients.
    Respir Med. 2016;117:116-21.
    PubMed     Text format     Abstract available


  71. KOSKELA HO, Purokivi MK, Kokkarinen J
    Stepping down from combination asthma therapy: The predictors of outcome.
    Respir Med. 2016;117:109-15.
    PubMed     Text format     Abstract available


  72. KJELLBERG S, Houltz BK, Zetterstrom O, Robinson PD, et al
    Clinical characteristics of adult asthma associated with small airway dysfunction.
    Respir Med. 2016;117:92-102.
    PubMed     Text format     Abstract available


  73. PAPAIOANNOU AI, Kostikas K, Manali ED, Papadaki G, et al
    Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.
    Respir Med. 2016;117:14-26.
    PubMed     Text format     Abstract available


    July 2016
  74. SUAREZ-CUARTIN G, Chalmers JD, Sibila O
    Diagnostic challenges of bronchiectasis.
    Respir Med. 2016;116:70-7.
    PubMed     Text format     Abstract available


  75. MIRABELLI MC, Hsu J, Gower WA
    Comorbidities of asthma in U.S. children.
    Respir Med. 2016;116:34-40.
    PubMed     Text format     Abstract available


  76. USMANI OS, Singh D, Spinola M, Bizzi A, et al
    The prevalence of small airways disease in adult asthma: A systematic literature review.
    Respir Med. 2016;116:19-27.
    PubMed     Text format     Abstract available


  77. DIMAKOU K, Triantafillidou C, Toumbis M, Tsikritsaki K, et al
    Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.
    Respir Med. 2016;116:1-7.
    PubMed     Text format     Abstract available


    June 2016
  78. RADEMACHER J, Ringshausen FC, Suhling H, Fuge J, et al
    Lung transplantation for non-cystic fibrosis bronchiectasis.
    Respir Med. 2016;115:60-5.
    PubMed     Text format     Abstract available


  79. BUHL R, Korn S, Menzies-Gow A, Aubier M, et al
    Assessing biomarkers in a real-world severe asthma study (ARIETTA).
    Respir Med. 2016;115:7-12.
    PubMed     Text format     Abstract available


  80. OHRMALM L, Malinovschi A, Wong M, Levinson P, et al
    Presence of rhinovirus in the respiratory tract of adolescents and young adults with asthma without symptoms of infection.
    Respir Med. 2016;115:1-6.
    PubMed     Text format     Abstract available


    May 2016
  81. HEFFLER E, Crimi N
    Asthma control and bronchodilator response.
    Respir Med. 2016 May 15. pii: S0954-6111(16)30096.
    PubMed     Text format    


  82. RAJAURE Y, Kumar B, Sahoo K, T V, et al
    Bronchodilator response not a significant marker of poor asthma control.
    Respir Med. 2016 May 10. pii: S0954-6111(16)30076.
    PubMed     Text format    


    April 2016
  83. PATEL MS, Donaldson AV, Lewis A, Natanek SA, et al
    Klotho and smoking--An interplay influencing the skeletal muscle function deficits that occur in COPD.
    Respir Med. 2016;113:50-6.
    PubMed     Text format     Abstract available


  84. JACOB R, Bentur L, Brik R, Shavit I, et al
    Is capnometry helpful in children with bronchiolitis?
    Respir Med. 2016;113:37-41.
    PubMed     Text format     Abstract available


  85. SPIELMANNS M, Gloeckl R, Schmoor C, Windisch W, et al
    Effects on pulmonary rehabilitation in patients with COPD or ILD: A retrospective analysis of clinical and functional predictors with particular emphasis on gender.
    Respir Med. 2016;113:8-14.
    PubMed     Text format     Abstract available


  86. RODRIGUE C, Beauchesne MF, Savaria F, Forget A, et al
    Adverse events among COPD patients treated with long-acting anticholinergics and beta2-agonists in an outpatient respiratory clinic.
    Respir Med. 2016;113:65-73.
    PubMed     Text format     Abstract available


    March 2016
  87. RUTTEN EP
    Comment on "Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study".
    Respir Med. 2016;112:130.
    PubMed     Text format    


  88. HUSSEIN SH, Nielsen LP, Dolberg MK, Dahl R, et al
    Response to Dr. Rutten's comment on "Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study".
    Respir Med. 2016;112:131.
    PubMed     Text format    


  89. WELTE T, Chapman KR, Magnussen H, Miravitlles M, et al
    Current thinking and new paradigm for COPD.
    Respir Med. 2016;112:126-7.
    PubMed     Text format     Abstract available


  90. ONATIBIA-ASTIBIA A, Martinez-Pinilla E, Franco R
    The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
    Respir Med. 2016;112:1-9.
    PubMed     Text format     Abstract available


  91. GREEN CE, Parr DG, Edgar RG, Stockley RA, et al
    Lung density associates with survival in alpha 1 antitrypsin deficient patients.
    Respir Med. 2016;112:81-7.
    PubMed     Text format     Abstract available


  92. DISANTOSTEFANO RL, Hinds D, Le HV, Barnes NC, et al
    Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.
    Respir Med. 2016;112:88-96.
    PubMed     Text format     Abstract available


  93. NIN CS, de Souza VV, do Amaral RH, Schuhmacher Neto R, et al
    Thoracic lymphadenopathy in benign diseases: A state of the art review.
    Respir Med. 2016;112:10-7.
    PubMed     Text format     Abstract available


  94. DONOHUE JF, Singh D, Munzu C, Kilbride S, et al
    Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials.
    Respir Med. 2016;112:65-74.
    PubMed     Text format     Abstract available


    February 2016
  95. WORTH H, Buhl R, Criee CP, Kardos P, et al
    The 'real-life' COPD patient in Germany: The DACCORD study.
    Respir Med. 2016;111:64-71.
    PubMed     Text format     Abstract available


  96. BARRECHEGUREN M, Monteagudo M, Ferrer J, Borrell E, et al
    Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study.
    Respir Med. 2016;111:47-53.
    PubMed     Text format     Abstract available


  97. ROBERTS NJ, Patel IS, Partridge MR
    The diagnosis of COPD in primary care; gender differences and the role of spirometry.
    Respir Med. 2016;111:60-3.
    PubMed     Text format     Abstract available


  98. WACKER ME, Jorres RA, Schulz H, Heinrich J, et al
    Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study.
    Respir Med. 2016;111:39-46.
    PubMed     Text format     Abstract available


  99. CHECKLEY W, Foreman MG, Bhatt SP, Dransfield MT, et al
    Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
    Respir Med. 2016;111:30-8.
    PubMed     Text format     Abstract available


    January 2016
  100. BOLAND MR, van Boven JF, Kruis AL, Chavannes NH, et al
    Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence.
    Respir Med. 2016;110:34-45.
    PubMed     Text format     Abstract available


  101. PRINS HJ, Daniels JM, Lindeman JH, Lutter R, et al
    Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial.
    Respir Med. 2016;110:46-52.
    PubMed     Text format     Abstract available


  102. MAIO S, Baldacci S, Carrozzi L, Pistelli F, et al
    Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study.
    Respir Med. 2016;110:58-65.
    PubMed     Text format     Abstract available


  103. JARENBACK L, Ankerst J, Bjermer L, Tufvesson E, et al
    Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
    Respir Med. 2016;110:28-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: